Evidence map›Paper›PMID 33234107›Full record

Observational studyBMC cardiovascular disorders2020

Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study.

Fernando Luís Scolari, Daniel Schneider, Débora Vacaro Fogazzi, Miguel Gus, Marciane Maria Rover, Marcely Gimenes Bonatto, Gustavo Neves de Araújo, André Zimerman, Daniel Sganzerla, Lívia Adams Goldraich and 6 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC cardiovascular disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. SCAI Door to Lactate Clearance (SCAI DLC) Cardiogenic Shock Initiative: Definition, Hypothesis, and Call to Action.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
  7. Review
  8. Review
  9. Current and novel biomarkers in cardiogenic shock.European journal of heart failure · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Fernando Luís ScolariResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos 630, 10º andar, Porto Alegre, RS, 90035-001, Brazil. fernando.scolari@hmv.org.br.ORCID 0000-0003-2150-6337
Daniel SchneiderResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos 630, 10º andar, Porto Alegre, RS, 90035-001, Brazil.
Débora Vacaro FogazziResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos 630, 10º andar, Porto Alegre, RS, 90035-001, Brazil.
Miguel GusDivision of Cardiology, HMV, Rua Tiradentes, 333, Porto Alegre, RS, 90560-030, Brazil.
Marciane Maria RoverDivision of Cardiology, HMV, Rua Tiradentes, 333, Porto Alegre, RS, 90560-030, Brazil.
Marcely Gimenes BonattoCardiology Department, Transplant Division, Irmandade Hospital da Santa Casa de Misericórdia de Curitiba, Praça Rui Barbosa, 694, Curitiba, PR, 80010-030, Brazil.
Gustavo Neves de AraújoDivision of Cardiology, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos 630, Porto Alegre, RS, 90035-001, Brazil.
André ZimermanPostgraduate Program in Health Sciences: Cardiology and Cardiovascular Sciences,, UFGRS, Rua Ramiro Barcelos, 2350, Porto Alegre, RS, 90035-007, Brazil.
Daniel SganzerlaResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos 630, 10º andar, Porto Alegre, RS, 90035-001, Brazil.
Lívia Adams GoldraichDivision of Cardiology, London Health Sciences Center and Western University, London, Canada.
Cassiano TeixeiraDivision of Critical Care Medicine, HMV, R. Tiradentes, 333, Porto Alegre, 90560-030, Brazil.
Gilberto FriedmanDivision of Critical Care Medicine, HCPA, Rua Ramiro Barcelos 630, Porto Alegre, 90035-001, Brazil.
Carisi Anne PolanczykDivision of Cardiology, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos 630, Porto Alegre, RS, 90035-001, Brazil.
Luis Eduardo RohdeDivision of Cardiology, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos 630, Porto Alegre, RS, 90035-001, Brazil.
Regis Goulart RosaResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos 630, 10º andar, Porto Alegre, RS, 90035-001, Brazil.
Rodrigo Vugman WainsteinResearch Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro Barcelos 630, 10º andar, Porto Alegre, RS, 90035-001, Brazil.
Hospital Moinhos de Vento · BRUniversidade Federal do Rio Grande do Sul · BRFundação Universitária de Cardiologia · BRIrmandade da Santa Casa de Misericórdia de São Paulo · BRWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the prognostic value of peak serum lactate and lactate clearance at several time points in cardiogenic shock treated with temporary mechanical circulatory support (MCS) using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or Impella CP

methodsSerum lactate and clearance were measured before MCS and at 1 h, 6 h, 12 h, and 24 h post-MCS in 43 patients at four tertiary-care centers in Southern Brazil. Prognostic value was assessed by univariable and multivariable analysis and receiver operating characteristic (ROC) curves for 30-day mortality.

resultsVA-ECMO was the most common MCS modality (58%). Serum lactate levels at all time points and lactate clearance after 6 h were associated with mortality on unadjusted and adjusted analyses. Lactate levels were higher in non-survivors at 6 h, 12 h, and 24 h after MCS. Serum lactate > 1.55 mmol/L at 24 h was the best single prognostic marker of 30-day mortality [area under the ROC curve = 0.81 (0.67-0.94); positive predictive value = 86%). Failure to improve serum lactate after 24 h was associated with 100% mortality.

conclusionsSerum lactate was an important prognostic biomarker in cardiogenic shock treated with temporary MCS. Serum lactate and lactate clearance at 24 h were the strongest independent predictors of short-term survival.

Indexed as

Extracorporeal Membrane OxygenationProsthesis ImplantationAdultBiomarkersBrazilFemaleHeart-Assist DevicesHumansLactic AcidMaleMiddle AgedOxygenators, MembranePredictive Value of TestsRetrospective StudiesRisk FactorsShock, CardiogenicBiomarkersLactic AcidCardiogenic shockExtracorporeal membrane oxygenationImpellaLactic acidMechanical circulatory support

Identifiers

PMID33234107
PMCPMC7687839
OpenAlexW3108435040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.